Obalon Therptcs (OBLN) – Investment Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Obalon Therptcs (NASDAQ: OBLN):

  • 11/10/2017 – Obalon Therptcs had its price target lowered by analysts at UBS AG from $20.00 to $16.00. They now have a “buy” rating on the stock.
  • 11/8/2017 – Obalon Therptcs was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Obalon Therapeutics, Inc. is a medical device company. It focused on developing and commercializing medical devices to treat obese and overweight. The company’s product consists of Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients. Obalon Therapeutics, Inc. is based in San Diego, California. “
  • 11/6/2017 – Obalon Therptcs had its price target lowered by analysts at BTIG Research from $20.00 to $15.00. They now have a “buy” rating on the stock.
  • 11/3/2017 – Obalon Therptcs had its “sell” rating reaffirmed by analysts at Northland Securities. They now have a $4.00 price target on the stock.

Obalon Therptcs (NASDAQ OBLN) opened at $7.97 on Tuesday. The company has a current ratio of 8.78, a quick ratio of 8.65 and a debt-to-equity ratio of 0.21. Obalon Therptcs has a 52 week low of $7.77 and a 52 week high of $13.18.

Obalon Therptcs (NASDAQ:OBLN) last announced its earnings results on Friday, November 3rd. The company reported ($0.55) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.12). The firm had revenue of $2.79 million during the quarter, compared to analysts’ expectations of $2.95 million. Obalon Therptcs had a negative net margin of 459.54% and a negative return on equity of 59.77%. sell-side analysts forecast that Obalon Therptcs will post -1.96 EPS for the current fiscal year.

Obalon Therapeutics, Inc is a United States-based commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company’s product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients.

Receive News & Ratings for Obalon Therptcs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Obalon Therptcs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply